City

Beijing (1)

Milwaukee (1)

Condition

T Cell Lymphoblastic Lymphoma (2)

Acute Myeloid Leukemia (1)

T Cell Acute Lymphoblastic Leukemia (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 1 (2)

Sponsor

Bioceltech Therapeutics, Ltd. (1)

Ehab L Atallah (1)

Collaborator

Intervention

bt-007 cd7 car-t cells (1)

xmab18968 - dose level -1 (1)

xmab18968 - dose level 0 (starting dose) (1)

xmab18968 - dose level 1 (1)

xmab18968 - dose level 2 (1)

xmab18968 - dose level 3 (1)

Study Documents

Intervention Type

biological (1)

drug (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

t cell lymphoblastic lymphoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

T Cell Lymphoblastic Lymphoma Trial in Beijing (BT-007 CD7 CAR-T cells)

Recruiting

T Cell Lymphoblastic Lymphoma

BT-007 CD7 CAR-T cells

Beijing, China

Beijing Cancer Hospital

Sep 22, 2022

Acute Myeloid Leukemia, T Cell Acute Lymphoblastic Leukemia, T Cell Lymphoblastic Lymphoma Trial in Milwaukee (XmAb18968 - Dose

Recruiting

Acute Myeloid Leukemia
+2 more

XmAb18968 - Dose level -1
+4 more

Milwaukee, Wisconsin

Froedtert Hospital & the Medical College of Wisconsin

Feb 15, 2022